Informações:
Falhas:
ID
27494
Descrição
Study of Camtobell Inj (Belotecan) on Weekly Schedule in Non-small Cell Lung Cancer (NSCLC) Patients Previously Treated With Chemotherapy; ODM derived from: https://clinicaltrials.gov/show/NCT01022671
Link
https://clinicaltrials.gov/show/NCT01022671
Palavras-chave
Versões (1)
- 17/11/2017 17/11/2017 -
Titular dos direitos
See clinicaltrials.gov
Transferido a
17 de novembro de 2017
DOI
Para um pedido faça login.
Licença
Creative Commons BY 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Eligibility Carcinoma, Non-Small-Cell Lung NCT01022671
Eligibility Carcinoma, Non-Small-Cell Lung NCT01022671
- StudyEvent: Eligibility
Similar models
Eligibility Carcinoma, Non-Small-Cell Lung NCT01022671
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Age
Item
19 years and older
boolean
C0001779 (UMLS CUI [1])
Non-Small Cell Lung Carcinoma Advanced Local TNM clinical staging | Non-small cell lung cancer metastatic TNM clinical staging
Item
histologically or cytologically confirmed locally advanced or metastatic nsclc(stage iiib or iv)
boolean
C0007131 (UMLS CUI [1,1])
C0205179 (UMLS CUI [1,2])
C0205276 (UMLS CUI [1,3])
C3258246 (UMLS CUI [1,4])
C0278987 (UMLS CUI [2,1])
C3258246 (UMLS CUI [2,2])
C0205179 (UMLS CUI [1,2])
C0205276 (UMLS CUI [1,3])
C3258246 (UMLS CUI [1,4])
C0278987 (UMLS CUI [2,1])
C3258246 (UMLS CUI [2,2])
Measurable lesion Quantity | Lesion Evaluable Quantity | Therapeutic radiology procedure Bone Marrow Percent
Item
≥ one measureable or evaluable lesion, <25% of the bone marrow had been irradiated
boolean
C1513041 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C0221198 (UMLS CUI [2,1])
C1516986 (UMLS CUI [2,2])
C1265611 (UMLS CUI [2,3])
C1522449 (UMLS CUI [3,1])
C0005953 (UMLS CUI [3,2])
C0439165 (UMLS CUI [3,3])
C1265611 (UMLS CUI [1,2])
C0221198 (UMLS CUI [2,1])
C1516986 (UMLS CUI [2,2])
C1265611 (UMLS CUI [2,3])
C1522449 (UMLS CUI [3,1])
C0005953 (UMLS CUI [3,2])
C0439165 (UMLS CUI [3,3])
Chemotherapy Platinum-Based
Item
prior platinum based chemotherapy
boolean
C0392920 (UMLS CUI [1,1])
C1514162 (UMLS CUI [1,2])
C1514162 (UMLS CUI [1,2])
ECOG performance status
Item
ecog ps ≤ 2
boolean
C1520224 (UMLS CUI [1])
Life Expectancy
Item
life expectancy > 3 months
boolean
C0023671 (UMLS CUI [1])
Organ function
Item
adequate organ function:
boolean
C0678852 (UMLS CUI [1])
Hematology | Absolute neutrophil count | Platelet Count measurement | Hemoglobin measurement
Item
hematology: anc ≥ 1.5×109/l, platelet ≥ 100×109/l, hemoglobin ≥ 9.0g/dl
boolean
C0200627 (UMLS CUI [1])
C0948762 (UMLS CUI [2])
C0032181 (UMLS CUI [3])
C0518015 (UMLS CUI [4])
C0948762 (UMLS CUI [2])
C0032181 (UMLS CUI [3])
C0518015 (UMLS CUI [4])
Liver function | Serum total bilirubin measurement | Aspartate aminotransferase measurement | Alanine aminotransferase measurement | Alkaline phosphatase measurement
Item
hepatic: total bilirubin ≤ 1.5×uln, ast/alt ≤ 2.0×uln, alp ≤2.0×uln
boolean
C0232741 (UMLS CUI [1])
C1278039 (UMLS CUI [2])
C0201899 (UMLS CUI [3])
C0201836 (UMLS CUI [4])
C0201850 (UMLS CUI [5])
C1278039 (UMLS CUI [2])
C0201899 (UMLS CUI [3])
C0201836 (UMLS CUI [4])
C0201850 (UMLS CUI [5])
Renal function | Creatinine measurement, serum
Item
renal: serum creatinine ≤ 1.5×uln
boolean
C0232804 (UMLS CUI [1])
C0201976 (UMLS CUI [2])
C0201976 (UMLS CUI [2])
Informed Consent
Item
signed a written informed consent
boolean
C0021430 (UMLS CUI [1])
Communicable Disease
Item
active infection
boolean
C0009450 (UMLS CUI [1])
Lesion of brain Symptomatic
Item
symptomatic brain lesion
boolean
C0221505 (UMLS CUI [1,1])
C0231220 (UMLS CUI [1,2])
C0231220 (UMLS CUI [1,2])
Cancer Other | Exception Basal cell carcinoma Treated | Exception Carcinoma in situ of uterine cervix Treated
Item
any other type of cancer during the previous 5 years except appropriately treated basal cell carcinoma of the skin or in situ carcinoma of the cervix
boolean
C1707251 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0007117 (UMLS CUI [2,2])
C1522326 (UMLS CUI [2,3])
C1705847 (UMLS CUI [3,1])
C0851140 (UMLS CUI [3,2])
C1522326 (UMLS CUI [3,3])
C1705847 (UMLS CUI [2,1])
C0007117 (UMLS CUI [2,2])
C1522326 (UMLS CUI [2,3])
C1705847 (UMLS CUI [3,1])
C0851140 (UMLS CUI [3,2])
C1522326 (UMLS CUI [3,3])
Comorbidity Severe
Item
severe concurrent diseases
boolean
C0009488 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0205082 (UMLS CUI [1,2])
Cancer treatment
Item
prior anticancer therapy within 4 weeks before enroll
boolean
C0920425 (UMLS CUI [1])
Pregnancy Test
Item
active pregnancy test
boolean
C0032976 (UMLS CUI [1])